Considering the involvement of PROK2 and its receptors in Aβ toxicity, the present study aimed to extend our research to rats chronically i.c.v. injected with Aβ, to the AD transgenic mouse model Tg2576, and subsequently to AD patients, mainly with the aim of detecting a potential biomarker. Here, PROK2 is linked to Alzheimer disease.